Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 8-K Event Material agreement
  2. CT ORDER Other Confidential Order
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  7. 3 Insider Initial Statement of Ownership
  8. DEF 14A Proxy Proxy Statement
  9. 8-K Event Material agreement
  10. 424B5 Offering Prospectus
  11. 4/A Derivatives Options or other derivatives
  12. 4/A Derivatives Options or other derivatives
  13. 4/A Derivatives Options or other derivatives
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. 4/A Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes CFO gave up 149 shares (to pay taxes)
  19. 4 Shares withheld for taxes Director gave up 1,491 shares (to pay taxes)
  20. PRE 14A Proxy Proxy Statement (Preliminary)

Page 28 of 68 · 1,358 filings